China cell therapy developer Neowise raises $29m
Chinese cell therapy company Neowise has raised an extended Series A round of CNY200m (USD 29m) from a group including Oriza Seed Fund Management and Marathon Venture Partners.
Shenzhen-listed urban mine resource exploitation company GEM Group, TongGao Capital, Zhongxin Capital, and Suzhou-based Leader Venture Capital also participated. Existing investor TF Capital re-upped....
More on Greater China
Latest News
Affinity recruits Australia head, re-hires executive from Quadrant
Affinity Equity Partners has strengthened its coverage of Australia and New Zealand with the recruitment of Nick Speer from The Riverside Company as a partner and local team leader and the rehiring of Mark Chudek from Quadrant Private Equity.
Bain pursues buyout of Australia's Estia Health
Bain Capital has offered to acquire Australia-listed aged care provider Estia Health for AUD 775.1m (USD 517.4m).
China’s JD Industrials completes $300m Series B
JD Industrials, a one-stop industrial products e-commerce platform under China’s JD.com has completed a USD 300m Series B round led by Abu Dhabi investors Mubadala and 42XFund.
JIP wins board approval for $15b Toshiba buyout
The board of Toshiba Corporation has approved a tender offer from Japan Industrial Partners (JIP) that values the company at approximately JPY 2trn (USD 15.3bn).